Last Updated: September 24, 2026

Details for New Drug Application (NDA): 020726

✉ Email this page to a colleague

NDA 020726 describes FEMARA, which is a drug marketed by Novartis Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the FEMARA profile page.

The generic ingredient in FEMARA is letrozole. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the letrozole profile page.

Summary for 020726

Tradename:	FEMARA
Applicant:	Novartis Pharms
Ingredient:	letrozole
Patents:	0

Pharmacology for NDA: 020726

Mechanism of Action	Aromatase Inhibitors

Suppliers and Packaging for NDA: 020726

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
FEMARA	letrozole	TABLET;ORAL	020726	NDA	Novartis Pharmaceuticals Corporation	0078-0249	0078-0249-15	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0078-0249-15)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	2.5MG
Approval Date:	Jul 25, 1997	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020726

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis Pharms	FEMARA	letrozole	TABLET;ORAL	020726-001	Jul 25, 1997	4,978,672	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.